INTRODUCTION
Malaria kills 1-2 million people every year, most of them children under age 5. The economic burden due to malaria in endemic countries is large, estimated at about 1-2% of the GDP in these countries (1). Nearly all malaria deaths are due to Plasmodium falciparum, a protozoan parasite that lives in human red blood cells during its asexual life cycle. Drug resistance in Plasmodium falciparum is an enormous problem and new antimalarial agents are desperately needed. In the effort to develop new treatments for malaria, study of hemoglobin degradation in the parasite food vacuole has generated substantial interest since it is a major metabolic pathway of the parasite and is believed to be essential for parasite survival (2) .
A family of P. falciparum aspartic proteases called plasmepsins has been found to be important for initiation of hemoglobin degradation in vitro and in vivo (3, 4) and considerable effort is being spent developing potent plasmepsin inhibitors (5-9).
Plasmepsin II (PM II), for which recombinant enzyme can be expressed readily and the crystal structure is available, has been the primary focus of drug design efforts. However, in vivo potency of generated compounds has been limited. The malaria genome project has revealed that there are 10 plasmepsins in the P. falciparum genome (10) . Four of them, PM I, PM II, histo-aspartic protease (HAP, previously known as PM III) and PM IV reside in the food vacuole and can degrade hemoglobin or globin (4) . The four plasmepsins are highly homologous to each other, sharing more than 60% amino acid identity. HAP is unique in that it has a histidine in place of the first canonical aspartic acid, but is an active protease that may function by an aspartic or serine protease mechanism (4, 11) . Because of the high degree of similarity, the specific roles of the food vacuole plasmepsins in vivo has been unclear, and which of these genes (if any) are essential to the parasite has been unknown.
In order to address this question and to determine if a particular plasmepsin should be considered as the primary drug target, we systematically disrupted all four plasmepsin genes. Our results suggest that the four plasmepsins have overlapping roles in the hemoglobin degradation pathway, and that there is a selective advantage for P. falciparum to keep the multiple food vacuole plasmepsin genes in its genome.
EXPERIMENTAL PROCEDURES

Parasite culture, transfection and selection
Asexual stage P. falciparum clone 3D7 was cultured in human O + erythrocytes, 2%
hematocrit, under 5% CO 2 , 5% O 2 and 90% N 2 (12) . Except as stated, cultures were grown in rich medium (RPMI 1640 medium supplemented with 27 mM NaHCO 3 , 11 mM glucose, 0.37 mM hypoxanthine, 10 µg/ml gentamicin, and 5 g/l Albumax (Invitrogen, Grand Island NY)). Serum medium (Albumax replaced by 10% heat-inactivated human O -serum (Interstate Blood Bank Inc., Memphis TN)) was used for cultures being electroporated or under drug selection. For some experiments, an amino acid-limited medium was used, which was made by omission of all but five essential amino acids, cysteine, glutamic acid, glutamine, isoleucine, and methionine from rich medium (13) .
Parasite synchronization was done by 5% D-sorbitol treatment (14) . Ring-stage parasites at 5-8% parasitemia were transfected by electroporation with 100 µg of super-coiled transfection vectors (see below) using low voltage/high capacitance conditions (15) .
Following transfection, parasites were maintained in drug-free medium for 48 h at which time positive selection was initiated by addition of 10 nM WR99210 (Jacobus Pharmaceuticals, Princeton NJ) to the medium. Drug-resistant parasites appeared in 3 to 6 weeks. When parasites reached a parasitemia of ~ 2%, 4 or 10 µM ganciclovir (Roche, Indianapolis IN) was added to start negative selection. After 2 to 8 weeks, parasites appeared. The WR99210/ganciclovir doubly resistant parasites were cloned by limiting dilution and their genotypes were analyzed by Southern blotting and PCR.
Construction of transfection vectors
The parental plasmid pHHT-TK was obtained from Dr. Alan Cowman (16) . The PCR primers, restriction enzymes and DNA fragments used to construct the transfection vectors are listed in Table 1 . All DNA fragments were amplified from 3D7 genomic DNA by PCR, digested with indicated restriction enzymes, and cloned into the specific sites of pHHT-TK. The DNA sequences of all inserts were confirmed.
Southern blotting
Two clones from each knockout construct were analyzed. Genomic DNA was extracted from parasite infected red blood cells using QIAamp DNA Blood Mini Kit (Qiagen, Valencia CA). For each clone 1.5 µg of DNA was digested using the following restriction enzymes: ScaI for the PM I knockout (KO1) clones A9 and E9, StuI for the PM II knockout (KO2) clones C5 and D2, SpeI-MspI for the HAP knockout (KO3) clones G2
and G9, and PacI for the PM IV/I knockout (KO4/1) clones A5 and E5. 3D7 DNA was used as a control for each digestion. The digested DNA was resolved on 0.7% agarose gels for KO1, KO2 and KO3 clones, and on an 0.8% agarose gel for KO4/1 clones. Gels were blotted onto Nytran SuPerCharge membrane (Schleicher and Schuell, Keene NH) and signal generated by an AlkPhos Direct labeling and detection kit (Amersham Biosciences, UK) using the manufacturer's recommended hybridization and washing conditions. All blots were hybridized against human DHFR using a probe made by digestion of pHHT-TK with HindIII-BamHI. After stripping with 0.5% SDS, the blots were re-probed with gene-specific probes (PM I-5' for KO1, PM II-3' for KO2, and HAP-5' for KO3). In the case of KO4/1, an identically loaded blot was probed with PM IV-5'.
Antibodies and western blotting
Rabbit polyclonal antibodies 574 (anti-PM I) and 737 (anti-PM II) were described in (17) and anti-BiP was described in (18) . Mouse monoclonal antibodies 1C6-24 (anti-PM I), 13.9.2 (anti-PM IV) were described in (4), and 3F10-6 (anti-HAP) was generated as described in (19) . Rat antibody (anti-falcipain 2) was described in (20). For immunoblotting, parasites were separated from erythrocyte cytosol by treatment with icecold 0.1% saponin in PBS for 10 min on ice followed by a cold PBS wash. Parasite pellets were stored at -80˚C until use. Parasites were lysed by boiling in SDS-PAGE sample loading buffer. The lysates were resolved by 12% SDS-PAGE, and transferred to Protran nitrocellulose membrane (Schleicher and Schuell). Primary antibodies used were: 574 (1:1000) for KO1, 737 (1:5000) for KO2, 3F10-6 (1:5000) for KO3, and 1C6-24
(1:2000) and 13.9.2 (1:1000) for KO4/1. All blots were re-probed using anti-BiP to assess loading. The signal was developed with HRP-conjugated anti-rabbit IgG (1:3000) or antimouse IgG (1:3000) secondary antibodies and ECL Western blotting detection reagents (Amersham Biosciences).
Flow cytometry
The flow cytometry protocol was adapted from Barkan et al (21) . Here y is the percent of schizonts in the culture; x is the independent variable (time); t r is the period of the function in radians which is converted to degrees by the formula t d = (180 / π ) ⋅ t r ; and m 1 through m 5 are curve-fitting parameters which are not related to the period of the function. In all cases the R-values of the curve fitting was greater than 0.99.
Determination of EC 50 values for pepstatin A and E64
Inhibitor EC 50 values were determined essentially as described (13) . 
Statistical analysis
One tailed t-tests were employed to analyze the significance of the doubling times and cell cycle times of the knockouts as compared to 3D7. The P values from each test are listed in Table 2 .
Reagents
All reagents were from either Sigma (St. Louis MO) or Fisher (Fairlawn NJ) except as stated.
RESULTS
Disruption of food vacuole plasmepsin genes
Plasmepsins I, II, and IV and HAP are tandemly arranged on chromosome 14, spanning approximately 16 kb (Fig. 1A) . To disrupt the plasmepsin genes, a positive/negative selection strategy was employed (16) . Approximately 500-650 bp of homologous sequence from the 5' and 3' ends of each gene was amplified from 3D7 genomic DNA and cloned into plasmid pHHT-TK at sites flanking the positive selectable marker human DHFR (which confers resistance to the antifolate WR99210). The sequences were chosen so that regions of each plasmepsin gene necessary for formation of the active site would be deleted upon double crossover recombination. Following transfection, parasites were first selected with 10 nM WR99210, and then with 4 or 10 µM ganciclovir to obtain parasites that had undergone double crossover recombination (16).
We were able to recover parasites with individual disruptions of PM I, PM II and HAP.
This was confirmed by Southern blotting (Fig. 1B-D) and by PCR (data not shown). Two clones from each targeting experiment were analyzed. Using probes corresponding to the targeted region there was a 2.2 kb increase in migration of the restriction fragment as compared to parental 3D7 DNA, as predicted (Fig. 1B-D, left panels) . When the human DHFR gene was used as the probe, no signal was detected in the 3D7 lanes and bands of predicted sizes for recombination were detected for the knockout clones (Fig. 1B-D , right panels). We were not able to recover PM IV disrupted parasites in spite of multiple attempts with several different targeting constructs. As an alternative strategy we designed a double-knockout vector with targeting sequences homologous to the PM IV-5' end and the PM I-3' end (no gene is predicted for the PM IV/I intergenic region).
Following transfection and selection of this construct, parasites with disruption of both PM IV and PM I were successfully obtained (Fig. 1E) . The PM IV-5' probe detected the predicted 2.1 kb band in the 3D7 lane and the 9.0 kb band in the KO4/1 lanes.
Hybridization to human DHFR also detected a band of the same size in the KO4/1 lanes.
We further confirmed the disruption of each gene by western blotting using specific anti-PM antibodies (Fig. 2 ). Parasites were lysed and equal amounts of protein loaded in each lane for each experiment. As a loading control, blots were stripped and re-probed for BiP, an ER resident protein ( Fig. 2A-D 
Parasite growth analysis
Giemsa stained knockout clones appeared morphologically normal. In order to compare parental and knockout growth rates, we monitored parasite proliferation by flow cytometry. Two clones from each knockout line and two independently maintained 3D7
cultures were grown asynchronously in rich medium and sampled approximately every 24 h for 1 week. The samples were fixed and stained with the DNA dye propidium iodide and parasitemia was counted by flow cytometry. After 7 days, the fold increase of both KO2 clones was about 80% of 3D7 (Fig. 3B ) and the KO4/1 clones were about 60% of 3D7 (Fig. 3D) . The growth of the KO1 and KO3 clones relative to 3D7 was not significantly different (Fig. 3A,C) . We fitted these data to an exponential growth curve and calculated doubling times (see Experimental Procedures). Compared to 3D7, KO2
doubling time was 5% longer and that of KO4/1 was 9% longer ( Table 2 ).
To test the possibility that the slow growth of KO2 and KO4/1 was due to an extended cell cycle, we monitored the growth of synchronous parasites for 56 hours with frequent sampling (26 samplings total, at approximately 2 hour intervals). Cultures were analyzed by flow cytometry and the percent of parasites at the schizont stage (post S-phase) was plotted against time (Fig. 4) . As expected, the curves were periodic and fitted an exponential sine wave function (R > 0.
99, see Experimental Procedures). A one-tailed
Student's t-test of the cell cycle times indicates that there is no significant difference between 3D7 and any of the knockouts (Table 2) . Similar results were obtained by plotting either the percent ring or percent trophozoite forms from this same experiment (not shown).
Parasite growth in amino acid-limited medium
An amino acid-limited medium was used to test parasite growth. This medium contains the 5 amino acids that are lacking or limited in hemoglobin and forces the parasites to rely on hemoglobin degradation to obtain amino acids to sustain its growth (13) . A growth rate analysis, similar to that in rich medium, was performed. All cultures grew more slowly in amino acid-limited medium, with approximately 1/20th of the overall growth in rich medium after 7 days (Fig. 5A-D) . The slow-growth phenotype of the KO4/1 clones is the most obvious, being about 60% of the 3D7 level in one week with KO1, KO2, and KO3 clones 70%-80% of the 3D7 level. The doubling times were calculated and are listed in Table 2 . Doubling times for KO1, KO2 and KO3 clones were 4-5% longer than for 3D7, while those of KO4/1 clones were 13% longer, all significant differences.
Sensitivities to pepstatin A and E64
Since both aspartic and cysteine protease activities participate in hemoglobin degradation in the food vacuole, we were interested to see if the susceptibility of knockouts to aspartic and cysteine protease inhibitors would change. The EC 50 values of pepstatin A and E64
for each clone were determined and are reported as percent inhibition relative to 3D7
( 
DISCUSSION
Among all Plasmodium species that infect humans and other vertebrates, only P.
falciparum has been reported to have multiple food vacuole plasmepsins (22, 23) . Our gene disruption study supports the idea that there is a selective advantage for P.
falciparum to keep all four food vacuole plasmepsin genes actively expressed. The growth of PM II and IV/I knockout parasites is less than that of 3D7 in rich medium, and growth of all four knockouts is reduced in amino acid-limited medium ( The doubling time of 3D7 in amino acid-limited medium is about 50% longer than in rich medium. Clearly the parasites require exogenous amino acids for optimal growth.
However, they are able to grow without most exogenous amino acids, presumably using hemoglobin as an amino acid source. Knockout parasites were more impaired relative to 3D7 in limited medium than in rich medium (Table 2 ). This tells us that degradation of hemoglobin for use as an amino acid source is important for parasite growth, and that plasmepsins are important for hemoglobin degradation. Interestingly, the plasmepsin knockouts were not slower at progressing through the life cycle, suggesting that it is their multiplication efficiency that is impaired. Fewer productive progeny are produced (7.7 per cycle for KO4/1 compared to 9.3 per cycle for 3D7, Table 2 ). Whether this is due to decreased DNA synthesis, merozoite packaging or release, invasion or establishment in the new red blood cell, could not be determined.
Despite the slow-growth phenotypes, all knockout clones can be continuously grown in culture and appear morphologically unchanged in both growth conditions tested. This suggests that there is a substantial degree of fitness compensation. The compensation could be due to either an alternative metabolic pathway, or to overlapping roles of duplicated genes (30, 31) . The major food vacuole cysteine protease falcipain-2 has been disrupted by Sijwali et al (32) . There is a temporary morphologic change in the food vacuole of the falcipain-2 knockout parasites, however, there is no growth defect.
Significantly, the EC 50 values of cysteine protease inhibitors such as E64 are somewhat reduced in the falcipain-2 knockout but the EC 50 of the aspartic protease inhibitor pepstatin A decreased dramatically. It appears that the loss of falcipain-2 can be compensated by an alternative pathway, which is highly reliant on plasmepsins.
In contrast, the EC 50 values for E64 and pepstatin are minimally changed in the plasmepsin knockouts, suggesting that fitness compensation for plasmepsin deficiencies relies more on the overlapping roles of the duplicated plasmepsin genes. Notably, there was no significant induction of other plasmepsins or falcipains in the knockouts. No induction of plasmepsins was seen in the falcipain 2 knockout either. Plasmodium falciparum may lack the capacity for such a response.
PM II has been the focus of most plasmepsin antimalarial drug development efforts. Our study suggests that parasites with loss of any one of the four food vacuole plasmepsins are still viable. Since the study was done under in vitro culture conditions, we don't know to what degree single plasmepsin interruption might help the human host to clear P.
falciparum parasites from the bloodstream. Nevertheless, it is likely that the substantial redundancy in the food vacuole plasmepsin system will limit the utility of highly selective agents. Targeting a single plasmepsin is unlikely to result in an effective antiparasitic agent unless it fortuitously cross-reacts with multiple plasmepsins. An alternative approach is to develop a pan-plasmepsin inhibitor (9) though cross-reactivity with host enzymes and retention of potency against different plasmepsins will be a challenge. A different approach to plasmepsin blockade will be to develop inhibitors to the maturase that processes proplasmepsins to their active form (33) . It appears that a single enzyme cleaves proplasmepsins at a conserved site at the pro-mature junction.
Inhibiting this activity prevents activation of all plasmepsins.
To the best of our knowledge, the PM IV/I double disruption reported in this study is the first case of a double knockout in Plasmodium, and also is the first disruption of two contiguous genes in Plasmodium with a single construct. It is not clear why we were unable to obtain a single PM IV disruptant. Conceivably, it is possible that PM I production is reliant on coordinate PM IV expression (e.g., PM IV could act as a chaperone for PM I and in its absence PM IV might be toxic to the cell). More likely, unknown technical hurdles to the integration of the knockout plasmids used, prevented knockout recovery. Certainly, failure to recover a knockout does not necessarily mean that the gene is essential, a principle for which the PM IV/I disruptant is a reminder.
Given the paucity of selectable markers available for Plasmodium transfection and given the many tandemly clustered gene families in the Plasmodium genome, the double knockout technique employed in this study should be useful to study Plasmodium gene function in the future.
HAP, histo-aspartic protease; HRP, horse radish peroxidase; KO, knockout; PBS, phosphate buffered saline; PM, plasmepsin; TK, thimidine kinase. Parasitemias were quantified by flow cytometry and plotted against time for A) KO1 clones A9 and E9; B) KO2 clones C5 and D2; C) KO3 clones G2 and G9; and D) KO4/1 clones A5 and E5. Symbols and curves are as in Fig. 3 .
FIGURE LEGENDS
Fig. 6 EC 50 values of pepstatin A and E64
The EC 50 values of each knockout clone relative to 3D7 (pepstatin A 7.5 ± 0.5 µM, n = 2; E64 1.1 ± 0.02 µM, n = 2) were graphed. Solid bars, relative EC 50 for pepstatin A; grey bars, relative EC 50 for E64. Error bars indicate the standard deviation of duplicate samples. 
